These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 15613062)

  • 41. [Analysis of efficacy and safety of administration of moxonidine in patients with arterial hypertension and hypertensive crises].
    Gaponova NI; Abdrakhmanov VR; Baratashvili VL; Tereshchenko SN
    Kardiologiia; 2011; 51(6):91-6. PubMed ID: 21878076
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Comparison of the effectiveness of moxonidine and prestarium in postmenopausal women with mild and moderate arterial hypertension].
    Bakhshaliev AB; Sabzalieva GM
    Klin Med (Mosk); 2006; 84(4):41-4. PubMed ID: 16755855
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"].
    Amado P; Vasconcelos N; Santos I; Almeida L; Nazaré J; Carmona J
    Rev Port Cardiol; 1999 Oct; 18(10):897-906. PubMed ID: 10590654
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The safety of long-term administration of losartan in current clinical practice: a non-intervention NCT-CZ 14/04/LOZ study].
    Krupicka J; Ceypová K; Kristenová P; Hauser T
    Vnitr Lek; 2008 Nov; 54(11):1031-8. PubMed ID: 19069675
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Selective imidazoline agonist moxonidine plus the ACE inhibitor ramipril in hypertensive patients with impaired insulin sensitivity: partners in a successful MARRIAGE?
    Rayner B
    Curr Med Res Opin; 2004 Mar; 20(3):359-67. PubMed ID: 15025845
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Clinicogenetic aspects of carbohydrate metabolism disorders and efficacy of their correction with moxonidine and metformine in patients with arterial hypertension].
    Kobalava ZhD; Tolkacheva VV; Ignat'ev IV; Glezer MG; Kuzin AI; Karpov IuA; Konradi AO; Zheleznykh EA
    Ter Arkh; 2005; 77(1):46-51. PubMed ID: 15759454
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effect of moxonidine on plasma lipid profile and on LDL subclass distribution.
    Elisaf MS; Petris C; Bairaktari E; Karabina SA; Tzallas C; Tselepis A; Siamopoulos KC
    J Hum Hypertens; 1999 Nov; 13(11):781-5. PubMed ID: 10578224
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Safety and tolerability of moxonidine in the treatment of hypertension.
    Schachter M; Luszick J; Jäger B; Verboom C; Söhlke E
    Drug Saf; 1998 Sep; 19(3):191-203. PubMed ID: 9747666
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [New, in Austria registered specialty drugs. Normoxin (moxonidine)].
    Kögler H; Raneburger J
    Wien Klin Wochenschr; 1993; 105(3):94-6. PubMed ID: 8447129
    [No Abstract]   [Full Text] [Related]  

  • 50. Effect of three months' treatment with irbesartan on blood and pulse pressure of hypertensive type 2 diabetic patients: open, observational study in 31,793 patients.
    Strutz F; Bramlage P; Paar WD
    Curr Med Res Opin; 2005 Sep; 21(9):1433-40. PubMed ID: 16197662
    [TBL] [Abstract][Full Text] [Related]  

  • 51. HYT-hypertension in Turkey: a cross-sectional survey on blood pressure control with calcium channel blockers alone or combined with other antihypertensive drugs.
    Seravalle G; Koylan N; Nalbantgil I; Caglar N; Quarti-Trevano F; Makel W; Grassi G; Fici F
    High Blood Press Cardiovasc Prev; 2015 Jun; 22(2):165-72. PubMed ID: 25900022
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Long-term antihypertensive therapy with moxonidine (cynt) in patients with insulin-independent diabetes mellitus].
    Lazebnik LB; Malichenko SB; Serebrov AN
    Ter Arkh; 1997; 69(6):59-64. PubMed ID: 9297279
    [No Abstract]   [Full Text] [Related]  

  • 53. Fixed-dose manidipine/delapril versus losartan/hydrochlorothiazide in hypertensive patients with type 2 diabetes and microalbuminuria.
    Kohlmann O; Roca-Cusachs A; Laurent S; Schmieder RE; Wenzel RR; Fogari R
    Adv Ther; 2009 Mar; 26(3):313-24. PubMed ID: 19330493
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Effect of imidazoline receptor agonist moxonidine on the state of microcirculation and renal function in patients with hypertension and diabetes mellitus type 2].
    Trusov VV; Aksenov KV
    Kardiologiia; 2003; 43(9):44-8. PubMed ID: 14682297
    [No Abstract]   [Full Text] [Related]  

  • 55. A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.
    Pepine CJ; Handberg EM; Cooper-DeHoff RM; Marks RG; Kowey P; Messerli FH; Mancia G; Cangiano JL; Garcia-Barreto D; Keltai M; Erdine S; Bristol HA; Kolb HR; Bakris GL; Cohen JD; Parmley WW;
    JAMA; 2003 Dec; 290(21):2805-16. PubMed ID: 14657064
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trials.
    Lacourcière Y; Neutel JM; Schumacher H
    Clin Ther; 2005 Nov; 27(11):1795-805. PubMed ID: 16368450
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Moxonidine. A new centrally active antihypertensive drug].
    Schrader J; Molderings GJ; Dominiak P
    Internist (Berl); 1992 Oct; 33(10):704-6. PubMed ID: 1428688
    [No Abstract]   [Full Text] [Related]  

  • 58. Hemodynamic and neurohumoral effects of moxonidine in patients with essential hypertension.
    Mitrovic V; Patyna W; Hüting J; Schlepper M
    Cardiovasc Drugs Ther; 1991 Dec; 5(6):967-72. PubMed ID: 1686975
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pecularities of prolonged use of moxonidine in patients with hypertension associated with metabolic syndrome.
    Kseneva SI; Borodulina EV; Semiglazova TA; Kulakova NV; Tarasova IV; Trifonova OJ; Gridneva TD; Udut VV
    Bull Exp Biol Med; 2011 Aug; 151(4):400-4. PubMed ID: 22448351
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Assessment of diet therapy effect on blood pressure of obese persons with and without antihypertensive therapy].
    Vasiljević N; Paunović K; Backović D; Jorga J; Ristić G; Plećas D; Stojanović S
    Vojnosanit Pregl; 2004; 61(4):379-85. PubMed ID: 15552533
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.